The p53 tumor suppressor is a universal sensor of genotoxic stress that reg
ulates the transcription of genes required for cell-cycle arrest and apopto
sis. In response to DN4 damage, the p53 protein is phosphorylated at its am
ino-terminus and becomes stabilized upon disruption of an interaction with
its negative regulator, MDM2. Subsequent phosphorylation and acetylation of
p53 promote different interactions with other proteins and with target gen
e regulatory elements to facilitate cell-cycle arrest, apoptosis, or adapta
tion in response to DNA damage. Downstream of p53, p21 is responsible for g
rowth arrest in G1, but other p53 target genes are responsible for G2 cell-
cycle arrest. In response to genotoxic insult, p53-induced apoptosis result
s from overlapping downstream pathways that both suppress mitogenic and sur
vival signaling and promote pro-apoptotic signaling. Adaptation to DNA dama
ge is manifested by p53-mediated expression of its negative regulator, MDM3
. The frequency of observed mutations in p53 predicts that its inactivation
is a requisite step in tumorigenesis, as p53 is mutated in approximately 5
0% of human tumors. Thus, it is likely that in the remaining tumors, geneti
c aberrations will occur in pathways that regulate p53 or in pathways direc
tly downstream of p53. The advances in the understanding of p53 signaling o
ver the Fast few years point to many potential overlapping signaling pathwa
ys, where mutations may occur as alternative modes to p53 mutation. (C) 200
0 Elsevier Science B.V. All rights reserved.